Radiation After No Axillary Nodal Sampling

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age40+
SponsorNYU Langone Health

About this trial

This is a single arm, pilot, prospective study to evaluate the safety of partial breast irradiation in women who undergo breast conserving surgery without sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). Baseline demographic and clinical information will be collected. All patients will complete the Breast Cancer Treatment Outcome Scale (BCTOS-13) questionnaire and the Functional Assessment of Chronic Illness Therapy-Comprehensive Score for financial Toxicity at baseline and at 2 years. All patients are required to have an axillary ultrasound prior to radiation start if this was not obtained pre-operatively.

Eligibility criteria

Qualifiers

Individuals assigned Female at birth, age 40 and older

Breast conserving surgery without SLNB or ALND

All patients should be capable of giving informed consent,

Willingness and ability to comply with scheduled visits, treatment plans, laboratory tests, and other study procedures.

Disqualifiers

Male

Transgender or non-binary individuals.

Mastectomy

Metastatic disease

Trial design

Treatments tested in this trial

  • Partial Breast Irradiation (PBI)

Treatment groups

105 Participants
are divided into 1 treatment group

Sponsors and collaborators